Apogee Therapeutics (APGE) EBITDA (2022 - 2026)
Apogee Therapeutics (APGE) reported EBITDA of -$82.8 million for Q1 2026, down 31.18% year-over-year from -$120.3 million in Q1 2025, and down 153.79% quarter-over-quarter from $153.9 million in Q4 2025.
Apogee Therapeutics (APGE) EBITDA (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of EBITDA data on file, last reported at -$82.8 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$82.8 million, down 31.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$73.3 million (down 84.56% YoY), and the FY2025 annual result was -$53.7 million, down 40.32% from the prior year.
- EBITDA slipped to -$82.8 million in Q1 2026 per APGE's latest filing, from $153.9 million in the prior quarter.
- Over five years, EBITDA peaked at $153.9 million in Q4 2025 and troughed at -$82.8 million in Q1 2026.
- A 5-year average of -$16.6 million and a median of -$26.1 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2024: EBITDA plunged 939.92% in 2023, then surged 425.74% in 2024.
- A 5-year view of EBITDA shows it stood at -$14.0 million in 2022, then plunged by 125.18% to -$31.5 million in 2023, then surged by 425.74% to $102.7 million in 2024, then surged by 49.76% to $153.9 million in 2025, then plunged by 153.79% to -$82.8 million in 2026.
- Business Quant data shows APGE's EBITDA at -$82.8 million in Q1 2026, $153.9 million in Q4 2025, and -$71.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Apogee Therapeutics | 6.29 Bn | 5.23 Bn | - | -82.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.77 Mn |
| Dec 31, 2025 | 153.87 Mn |
| Sep 30, 2025 | -71.28 Mn |
| Jun 30, 2025 | -73.17 Mn |
| Mar 31, 2025 | -63.10 Mn |
| Dec 31, 2024 | 102.74 Mn |
| Sep 30, 2024 | -45.46 Mn |
| Jun 30, 2024 | -33.93 Mn |
| Mar 31, 2024 | -32.60 Mn |
| Dec 31, 2023 | -31.54 Mn |
| Sep 30, 2023 | -20.71 Mn |
| Jun 30, 2023 | -18.89 Mn |
| Mar 31, 2023 | -12.53 Mn |
| Dec 31, 2022 | -14.01 Mn |
| Sep 30, 2022 | -19.66 Mn |
| Jun 30, 2022 | -1.82 Mn |